Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Heparin sodium 5,000units/1ml inj ampoules
0208010K0AAA9A9
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | 18 |
|
Heparin sodium 1,000units/1ml inj ampoules
0208010K0AAA7A7
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | 11 |
|
Heparin sodium 5,000units/0.2ml inj ampoules
0208010K0AAALAL
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | 8 |
|
Heparin sodium 25,000units/1ml inj ampoules
0208010K0AABFBF
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | 6 |
|
Heparin sodium 5,000units/5ml inj ampoules
0208010K0AAA8A8
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | 6 |
|
Heparin sodium 25,000units/5ml inj ampoules
0208010K0AABCBC
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | 2 |
|
Heparin sodium 5,000units/5ml solution for injection vials
0208010K0AAA4A4
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | 2 |
|
Heparin sodium 10,000units/10ml inj ampoules
0208010K0AAA2A2
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | 1 |
|
Heparin sodium 100units/1ml solution for injection ampoules
0208010K0AABJBJ
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | No data available |
|
Heparin sodium 125,000units/5ml solution for injection vials
0208010K0AAA6A6
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | No data available |
|
Heparin sodium 20,000units/20ml inj ampoules
0208010K0AAAZAZ
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | No data available |
|
Heparin sodium 25,000units/5ml solution for injection vials
0208010K0AAA5A5
|
Heparin sodium (Parenteral) | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 1,000units/1ml solution for injection ampoules
0208010K0BCAAA7
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 10,000units/10ml solution for injection ampoules
0208010K0BCAGA2
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 20,000units/20ml solution for injection ampoules
0208010K0BCAHAZ
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 25,000units/1ml solution for injection ampoules
0208010K0BCAHBF
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 25,000units/5ml solution for injection ampoules
0208010K0BCAIBC
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 5,000units/0.2ml solution for injection ampoules
0208010K0BCAEAL
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 5,000units/1ml solution for injection ampoules
0208010K0BCABA9
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Monoparin 5,000units/5ml solution for injection ampoules
0208010K0BCADA8
|
Monoparin | Heparin sodium | Cardiovascular System | No data available |
|
Multiparin 125,000units/5ml solution for injection vials
0208010K0BDACA6
|
Multiparin | Heparin sodium | Cardiovascular System | No data available |
|
Multiparin 25,000units/5ml solution for injection vials
0208010K0BDABA5
|
Multiparin | Heparin sodium | Cardiovascular System | No data available |
|
Multiparin 5,000units/5ml solution for injection vials
0208010K0BDAAA4
|
Multiparin | Heparin sodium | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.